Business Description
HCA Healthcare Inc
ISIN : US40412C1018
Total Employee Number:
320,000Compare
Compare
Traded in other countries / regions
HCA.USA0J1R.UKH1CA34.BrazilHCA.Mexico2BH.Germany1HCA.Italy IPO Date
2026-09-09Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -0.11 | |||||
Debt-to-Equity | -7.76 | |||||
Debt-to-EBITDA | 3.25 | |||||
Interest Coverage | 5.21 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.56 | |||||
Beneish M-Score | -2.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.6 | |||||
3-Year EBITDA Growth Rate | 13 | |||||
3-Year EPS without NRI Growth Rate | 21.2 | |||||
3-Year FCF Growth Rate | 31.9 | |||||
3-Year Book Growth Rate | -39.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 7.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 13.89 | |||||
Days Sales Outstanding | 51.8 | |||||
Days Payable | 37.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 8.7 | |||||
3-Year Average Share Buyback Ratio | 6.8 | |||||
Shareholder Yield % | 6.44 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.58 | |||||
Operating Margin % | 15.48 | |||||
Net Margin % | 8.77 | |||||
EBITDA Margin % | 20.33 | |||||
FCF Margin % | 7.66 | |||||
OCF Margin % | 14.23 | |||||
ROE % | Neg. Equity | |||||
ROA % | 11.22 | |||||
ROIC % | 18.68 | |||||
3-Year ROIIC % | 28.24 | |||||
ROC (Joel Greenblatt) % | 32.91 | |||||
ROCE % | 27.96 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.29 | |||||
PE Ratio without NRI | 14.37 | |||||
Shiller PE Ratio | 22.35 | |||||
Price-to-Owner-Earnings | 17.45 | |||||
PEG Ratio | 0.98 | |||||
PS Ratio | 1.25 | |||||
Price-to-Free-Cash-Flow | 16.47 | |||||
Price-to-Operating-Cash-Flow | 8.84 | |||||
EV-to-EBIT | 12.01 | |||||
EV-to-Forward-EBIT | 11.58 | |||||
EV-to-EBITDA | 9.23 | |||||
EV-to-Forward-EBITDA | 8.79 | |||||
EV-to-Revenue | 1.88 | |||||
EV-to-Forward-Revenue | 1.77 | |||||
EV-to-FCF | 24.41 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-DCF (FCF Based) | 1.18 | |||||
Price-to-Median-PS-Value | 1.1 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.23 | |||||
Earnings Yield (Greenblatt) % | 8.33 | |||||
FCF Yield % | 6.49 | |||||
Forward Rate of Return (Yacktman) % | 16.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HCA Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 67,078.199 | ||
| EPS (TTM) (€) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 363.5 - 365.2 | ||
| Shares Outstanding (Mil) | 216.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HCA Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HCA Healthcare Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-10 | In 150 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-01-27 10:00 | In 137 days | ||
| Fourth quarter earnings results for 2026 | 2027-01-27 | In 136 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-23 10:00 | In 41 days | ||
| Third quarter earnings results for 2026 | 2026-10-23 | In 40 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-24 09:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-07-24 | -- | ||
| RBC Global Healthcare Conference | 2026-05-20 11:30 | -- | ||
| First quarter earnings conference call for 2026 | 2026-04-24 10:00 | -- | ||
| First quarter earnings results for 2026 | 2026-04-24 | -- |
Show
Entries
HCA Healthcare Inc Frequently Asked Questions
What is HCA Healthcare Inc(WBO:HCAH)'s stock price today?
The current price of WBO:HCAH is €365.20. The 52 week high of WBO:HCAH is €365.20 and 52 week low is €363.50.
When is next earnings date of HCA Healthcare Inc(WBO:HCAH)?
The next earnings date of HCA Healthcare Inc(WBO:HCAH) is 2026-10-23 Est..
Does HCA Healthcare Inc(WBO:HCAH) pay dividends? If so, how much?
HCA Healthcare Inc(WBO:HCAH) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers